Showing results (1171-1180 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|June 8, 2023
Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain MetastasesRoshan S Prabhu, Tobi Akinyelu, Zachary K Vaslow, et al.
JAMA Oncology|June 8, 2023
Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A ReviewRobert Haddad, Rossella Elisei, Ana O Hoff, et al.
JAMA Oncology|October 19, 2023
Cancers Attributable to Infections in the US in 2017: A Meta-AnalysisKarena D Volesky-Avellaneda, Samantha Morais, Stephen D Walter, et al.
JAMA Oncology|September 14, 2023
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled TrialMichael F Gensheimer, Harriet Gee, Hiroki Shirato, et al.
JAMA Oncology|June 29, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors for Treatment of Hormone Receptor-Positive, ERBB2-Negative Breast Cancer: A ReviewCiara Catherine O'Sullivan, Robert Clarke, Matthew Philip Goetz, et al.
JAMA Oncology|March 5, 2026
Genomic Therapy Matching in Rare and Refractory CancersFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.
JAMA Oncology|March 12, 2026
Cancer Risk in Solid Organ Transplant Recipients With a Pretransplant Cancer HistoryJun Tao, Ruth M Pfeiffer, Shyfuddin Ahmed, et al.
JAMA Oncology|April 9, 2026
Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received PembrolizumabAdrien Rousseau, Stéphanie Foulon, David Planchard, et al.
JAMA Oncology|May 16, 2026
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical TrialJules Lansu, Judith V M G Bovée, Pètra M Braam, et al.
JAMA Oncology|April 16, 2026
18F-Fluorodeoxyglucose Positron Emission Tomography for Estimating Outcomes After Initial Treatment for Metastatic Breast Cancer: A Nonrandomized Clinical Cohort TrialJasper J L van Geel, Bertha Eisses, Sjoerd G Elias, et al.
Pageof 162